Local treatment of viral disease using photodynamic therapy.

[1]  M. Craglia,et al.  Conclusions and Future Prospects , 2004 .

[2]  C. Whitehurst,et al.  Photodynamic therapy for superficial bladder cancer under local anaesthetic , 2002, BJU international.

[3]  Guy Boivin,et al.  Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. , 2002, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[4]  C. Scully.  Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission. , 2002, Oral oncology.

[5]  J. Vachris,et al.  A randomized trial of trichloroacetic acid in human papillomavirus infection and mildly abnormal cervical smears , 2002 .

[6]  M. Wainwright.  The emerging chemistry of blood product disinfection. , 2002, Chemical Society reviews.

[7]  S. R. Abel,et al.  Verteporfin for Age-Related Macular Degeneration , 2001, The Annals of pharmacotherapy.

[8]  B. Rouse,et al.  Contribution of Vascular Endothelial Growth Factor in the Neovascularization Process during the Pathogenesis of Herpetic Stromal Keratitis , 2001, Journal of Virology.

[9]  J. Bourhis,et al.  Antiviral approaches for cancers related to Epstein-Barr virus and human papillomavirus. , 2001, The Lancet. Oncology.

[10]  M. Johnston.  Human papillomavirus associated with dysplasia in Barrett’s esophagus , 2001 .

[11]  H. Field.  Herpes simplex virus antiviral drug resistance--current trends and future prospects. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[12]  R. Angioli,et al.  Self-administered topical 5% imiquimod cream for external anogenital warts in adolescent girls , 2001 .

[13]  M. Wainwright,et al.  Methylene blue derivatives--suitable photoantimicrobials for blood product disinfection? , 2000, International journal of antimicrobial agents.

[14]  J. Goedert,et al.  Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. , 2000, Journal of the National Cancer Institute.

[15]  T. Dubbelman,et al.  Plasma Membrane Properties Involved in the Photodynamic Efficacy of Merocyanine 540 and Tetrasulfonated Aluminum Phthalocyanine , 2000, Photochemistry and photobiology.

[16]  M. Wainwright,et al.  Phenothiazine Photosensitizers. III. Activity of Methylene Blue Derivatives against Pigmented Melanoma Cell Lines , 2000, Journal of chemotherapy.

[17]  G. Gross.  Do we need antivirals for genital herpes simplex virus and human papillomavirus infection? , 1999, International journal of antimicrobial agents.

[18]  A. Moor,et al.  Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation , 1999, Gene Therapy.

[19]  M. Murakami,et al.  Human papillomavirus vaccines for cervical cancer. , 1999, Journal of immunotherapy.

[20]  R. Malek,et al.  Laser therapy of squamous cell dysplasia and carcinoma of the penis. , 1998, Urology.

[21]  B. Steinberg,et al.  Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long‐term results , 1998, The Laryngoscope.

[22]  M. Wainwright,et al.  Photodynamic antimicrobial chemotherapy (PACT). , 1998, Journal of Antimicrobial Chemotherapy.

[23]  S. Tyring.  Advances in the treatment of herpesvirus infection: the role of famciclovir. , 1998, Clinical therapeutics.

[24]  S. Jabłońska,et al.  Recombinant Interferon Beta Gel as an Adjuvant in the Treatment of Recurrent Genital Warts: Results of a Placebo-Controlled Double-Blind Study in 120 Patients , 1998, Dermatology.

[25]  S. Tyring,et al.  Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital Warts , 1998, Antimicrobial Agents and Chemotherapy.

[26]  E. A. Wachter,et al.  Simultaneous Two‐Photon Activation of Type‐I Photodynamic Therapy Agents , 1997, Photochemistry and photobiology.

[27]  J. McCutchan,et al.  Alternative Regimens for the Prophylaxis of Mycobacterium avium Complex in Acquired Immune Deficiency Syndrome (AIDS) , 1997 .

[28]  A. Ferenczy,et al.  Therapeutic approaches to genital warts. , 1997, The American journal of medicine.

[29]  R. Saxton,et al.  KTP Laser and Neutral Red Phototherapy of Human Squamous Cell Carcinoma , 1997, The Laryngoscope.

[30]  A. Moor,et al.  Primary Targets for Photoinactivation of Vesicular Stomatitis Virus by AIPcS4 or Pc4 and Red Light , 1997, Photochemistry and photobiology.

[31]  M. E. Kenney,et al.  Action spectra (660–700 nm) for virus inactivation and red cell damage photosensitized by the silicon phthalocyanine Pc 4 , 1996, Lasers in Medical Science.

[32]  H. Kostron,et al.  Unusual adverse reaction in a patient sensitized with Photosan 3. , 1996, Journal of photochemistry and photobiology. B, Biology.

[33]  R. Tindle.  Human papillomavirus vaccines for cervical cancer. , 1996, Current opinion in immunology.

[34]  M W Berns,et al.  Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid. , 1996, American journal of obstetrics and gynecology.

[35]  R. G. Frank,et al.  Photodynamic therapy for condylomata acuminata with local application of 5-aminolevulinic acid. , 1996, Genitourinary medicine.

[36]  B. Bachmann,et al.  Target structures for HIV‐1 inactivation by methylene blue and light , 1995, Journal of medical virology.

[37]  Raymond Bonnett,et al.  Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy , 1995 .

[38]  C. M. Allen,et al.  SULFOPHTHALOCYANINES FOR PHOTODYNAMIC INACTIVATION OF VIRUSES IN BLOOD PRODUCTS: EFFECT OF STRUCTURAL MODIFICATIONS , 1995, Photochemistry and photobiology.

[39]  D. Meruelo,et al.  Hypericin as an inactivator of infectious viruses in blood components , 1995, Transfusion.

[40]  I. Maruyama,et al.  p53 gene mutations in skin cancers with underlying disorders. , 1995, Journal of dermatological science.

[41]  M. E. Kenney,et al.  NEW PHTHALOCYANINES FOR PHOTODYNAMIC VIRUS INACTIVATION IN RED BLOOD CELL CONCENTRATES , 1994, Photochemistry and photobiology.

[42]  J. Kelly,et al.  Photochemical interactions of methylene blue and analogues with DNA and other biological substrates. , 1993, Journal of photochemistry and photobiology. B, Biology.

[43]  J. Levy,et al.  Photosensitizers as virucidal agents. , 1993, Journal of photochemistry and photobiology. B, Biology.

[44]  G. Bachowski,et al.  PHOTOPEROXIDATION OF CHOLESTEROL IN HOMOGENEOUS SOLUTION, ISOLATED MEMBRANES, AND CELLS: COMPARISON OF THE 5α‐ AND 6β‐HYDROPEROXIDES AS INDICATORS OF SINGLET OXYGEN INTERMEDIACY , 1992 .

[45]  A. Girotti,et al.  PHOTODYNAMIC LIPID PEROXIDATION IN BIOLOGICAL SYSTEMS * , 1990, Photochemistry and photobiology.

[46]  H. Balfour,et al.  Herpes Simplex Virus Resistant to Acyclovir: A Study in a Tertiary Care Center , 1990 .

[47]  Christopher S. Foote,et al.  Chemical mechanisms of photodynamic action , 1990, Other Conferences.

[48]  R. Straight,et al.  INACTIVATION AND MUTAGENESIS OF Herpes VIRUS BY PHOTODYNAMIC TREATMENT WITH THERAPEUTIC DYES , 1989, Photochemistry and photobiology.

[49]  C. Crumpacker,et al.  Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. , 1989, The New England journal of medicine.

[50]  W. R. Midden,et al.  A NEW BIOLOGICAL TARGET OF FUROCOUMARINS: PHOTOCHEMICAL FORMATION OF COVALENT ADDUCTS WITH UNSATURATED FATTY ACIDS , 1988, Photochemistry and photobiology.

[51]  B. Leventhal,et al.  Recurrent respiratory papillomatosis. , 1985, Journal of biological response modifiers.

[52]  E. H. Simon,et al.  Photosensitization of herpes simplex virus type 1 with neutral red. , 1978, The Journal of general virology.

[53]  C. Papa,et al.  Photodye herpes therapy--Cassandra confirmed? , 1977, JAMA.

[54]  L. Kucera,et al.  Oncogenic transformation of rat embryo fibroblasts with photoinactivated herpes simplex virus: rapid in vitro cloning of transformed cells. , 1977, The Journal of general virology.

[55]  F. Rapp,et al.  ONCOGENIC POTENTIAL OF HERPES SIMPLEX VIRUS IN MAMMALIAN CELLS FOLLOWING PHOTODYNAMIC INACTIVATION , 1977, Photochemistry and photobiology.

[56]  J. Regan,et al.  THE EFFECT OF PROFLAVINE PLUS VISIBLE LIGHT ON THE DNA OF HUMAN CELLS * , 1977, Photochemistry and photobiology.

[57]  L. Hester,et al.  PHOTODYNAMIC TREATMENT OF HERPES SIMPLEX VIRUS INFECTION IN VITRO , 1976, Photochemistry and photobiology.

[58]  T. Fife,et al.  Effect of neutral red and light on Herpesvirus hominis type 1 in cell culture. , 1976, The Journal of infectious diseases.

[59]  K. Arndt,et al.  Failure of neutral-red photodynamic inactivation in recurrent herpes simplex virus infections. , 1975, The New England journal of medicine.

[60]  R. Goldenberg,et al.  DERMATITIS FROM NEUTRAL RED THERAPY OF HERPES GENITALIS , 1975, Obstetrics and gynecology.

[61]  D. O'day,et al.  Proflavine photodynamic viral inactivation in herpes simplex keratitis. , 1975, American journal of ophthalmology.

[62]  A. Roome,et al.  Neutral red with photoinactivation in the treatment of herpes genitalis. , 1975, The British journal of venereal diseases.

[63]  W. Morison,et al.  Anti‐viral treatment of warts , 1975, The British journal of dermatology.

[64]  C. Wallis,et al.  Herpes genitalis treated by photodynamic inactivation of virus. , 1973, American journal of obstetrics and gynecology.

[65]  Edgar B. Smith,et al.  Photodynamic Inactivation of Herpes Simplex: Report of a Clinical Trial , 1973 .

[66]  C. Wallis,et al.  Photodynamic Treatment of Herpes Keratitis , 1972, Infection and immunity.

[67]  C. Wallis,et al.  Photodynamically inactivated vaccines prepared by growing viruses in cells containing neutral red. , 1967, Journal of immunology.

[68]  W. S. Morgan,et al.  Structure of neutral red and other 2,8-substituted aminophenazines. , 1967, The Journal of organic chemistry.

[69]  C. Wallis,et al.  PHOTODYNAMIC INACTIVATION OF ANIMAL VIRUSES * : A REVIEW , 1965, Photochemistry and photobiology.

[70]  C. Wallis,et al.  IRREVERSIBLE PHOTOSENSITIZATION OF VIRUSES. , 1964, Virology.

[71]  C. Wallis,et al.  PHOTODYNAMIC INACTIVATION OF POLIOVIRUS. , 1963, Virology.

[72]  F. L. Schaffer.  Binding of proflavine by and photoinactivation of poliovirus propagated in the presence of the dye. , 1962, Virology.

[73]  J. Melnick,et al.  The incorporation of neutral red and acridine orange into developing poliovirus particles making them photosensitive. , 1961, Virology.

[74]  S. Baron,et al.  Inactivation of viruses by the photodynamic action of toluidine blue. , 1960, Journal of immunology.

[75]  E. W. Schultz.  Inactivation of Staphyloccus Bacteriophage by Methylene Blue. , 1928 .

[76]  M. Wainwright.  Pathogen inactivation in blood products. , 2002, Current medicinal chemistry.

[77]  E. Franco,et al.  Persistent human papillomavirus infection and cervical neoplasia. , 2002, The Lancet. Oncology.

[78]  L. Corash.  Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates. , 2000, Vox sanguinis.

[79]  R. Goodrich.  The use of riboflavin for the inactivation of pathogens in blood products. , 2000, Vox sanguinis.

[80]  T. Mang,et al.  Tin ethyl etiopurpurin—induced photodynamic therapy for the treatment of human immunodeficiency virus—associated kaposi's sarcoma , 1998 .

[81]  Z. Malik,et al.  Treatment of viral infections with 5‐aminolevulinic acid and light , 1997, Lasers in surgery and medicine.

[82]  H. Mohr,et al.  Infection cycle of herpes viruses after photodynamic treatment with methylene blue and light. , 1997, Beitrage zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine.

[83]  B. Lambrecht,et al.  Photodynamic virus inactivation of blood components. , 1995, Immunological investigations.

[84]  J. V. van Lier,et al.  Photodynamic inactivation of herpes viruses with phthalocyanine derivatives. , 1994, Journal of photochemistry and photobiology. B, Biology.

[85]  A. Abramson,et al.  Dihematoporphyrin Ether‐Induced photosensitivity in laryngeal papilloma patients , 1990, Lasers in surgery and medicine.

[86]  A. Harriman,et al.  Inactivation of tumours and viruses via effcient photoisomerisation , 1989 .

[87]  A. Abramson,et al.  The pathologic effects of photodynamic therapy on the larynx. Experimental study. , 1988, Archives of otolaryngology--head & neck surgery.

[88]  N. Shipkowitz,et al.  Photodynamic inactivation of influenza and herpes viruses by hematoporphyrin. , 1987, Antiviral research.

[89]  J E Hearst,et al.  Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry. , 1985, Annual review of biochemistry.

[90]  H. Rosenkranz,et al.  Alteration of human cellular DNA by neutral red in the presence of visible light. , 1979, Mutation research.

[91]  M. Jarrat.  Photodynamic inactivation of Herpes simplex virus. , 1977, Photochemistry and photobiology.